NASDAQ:AYTU | Free Cash Flow | AYTU BIOPHARMA, INC

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-11-30 to 2025-09-30
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-09-30-$618,000.00$0.00-$618,000.00-31.45%
2025-06-30$2.8M$17,000.00$2.79M
2024-09-30-$1.19M$136,000.00-$1.33M-89.96%
2024-06-30-$788,000.00
2023-09-30-$211,000.00
2023-06-30$9.37M
2022-09-30-$9.15M
2022-06-30-$7.1M
2021-09-30-$3.79M
2021-06-30-$6.28M
2021-03-31$19.7M
2020-09-30-$7.98M
2020-06-30-$7.76M-$5.85M-$13.61M
2020-03-31$20.6M
2019-09-30-$2.99M$0.00-$2.99M
2019-06-30-$3.47M$0.00-$3.47M
2018-09-30-$2.74M$6,065.00-$2.75M
2018-06-30-$4.54M$0.00-$4.54M-831.25%
2017-09-30-$4.22M
2017-06-30-$3.27M$58,173.00-$3.33M
2016-09-30-$5.33M$4,721.00-$5.34M
2016-06-30-$2.66M$49,355.00-$2.71M
2015-09-30-$2.16M$3,554.00-$2.16M
2015-06-30-$1.79M$0.00-$1.79M
2014-11-30-$9,327.00
2014-09-30-$2.19M
2014-06-30-$1.77M
2013-11-30-$6,858.00
2013-08-31-$5,234.00
2012-11-30-$8,916.00
2012-08-31-$12,564.00
2011-11-30-$11,011.00$0.00-$11,011.00
2011-08-31-$9,298.00
2010-11-30-$11,883.00$0.00-$11,883.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-06-30-$1.94M$228,000.00-$2.17M
2024-06-30-$1.39M$329,000.00-$1.72M
2023-06-30-$5.13M
2022-06-30-$28.82M
2021-06-30-$25.96M
2020-06-30-$28.37M$0.00-$28.37M
2019-06-30-$13.83M$59,848.00-$13.89M
2018-06-30-$15.94M$74,707.00-$16.02M
2017-06-30-$13.83M$111,608.00-$13.94M
2016-06-30-$10.66M$252,932.00-$10.91M
2015-06-30-$6.63M$0.00-$6.63M
2014-06-30-$5.5M$9,298.00-$5.51M
2013-08-31-$37,704.00
2012-08-31-$37,849.00
2011-08-31-$64,818.00